Orforglipron without an injection

Foundayo Oral GLP-1 Weight Loss Tablets: W8MD Guide

Foundayo is an FDA-approved once-daily oral GLP-1 receptor agonist for chronic weight management in qualifying adults and may be taken with or without food.

Contact W8MD

What is Foundayo?

Foundayo is the brand name for orforglipron, a nonpeptide GLP-1 receptor agonist tablet approved in 2026. It is used with reduced-calorie nutrition and increased physical activity in adults with obesity or overweight plus at least one weight-related condition.

The labeled starting dose is 0.8 mg daily, followed after at least 30 days by 2.5 mg and then 5.5 mg. Further increases to 9, 14.5 or 17.2 mg depend on response and tolerability. Tablets are swallowed whole and may be taken with or without food.

W8MD original image, used with permission. View the source image.

Results and safety

In the 72-week approval trial without diabetes, mean loss ranged from 7.4% with 5.5 mg to 11.1% with 17.2 mg, versus 2.1% with placebo. Outcomes were lower in the trial with type 2 diabetes. These are averages, not guarantees.

Common effects include nausea, constipation, diarrhea, vomiting, indigestion, abdominal symptoms, headache and fatigue. Label precautions include pancreatitis, severe GI reactions, dehydration-related kidney injury, hypoglycemia, retinopathy in diabetes, gallbladder disease and aspiration risk. It carries an MTC/MEN 2 contraindication and should not be combined with another GLP-1 agonist.

Who may prefer Foundayo?

It may appeal to an eligible adult who strongly prefers a tablet, can adhere daily and has suitable coverage and no contraindication. It is not automatically more effective, safer or less expensive than Wegovy, Zepbound or traditional oral medicines.

Important: Prescription treatment requires an individualized evaluation. Eligibility, product, formulation, dose, pharmacy availability, FDA status, insurance coverage and total cost vary. Weight-loss medicines should not be used during pregnancy. Do not start, stop, combine or change a medicine without the prescribing clinician.

Frequently asked questions

Does Foundayo need an empty stomach?

No. The label permits use with or without food.

Is Foundayo compounded semaglutide?

No. It is an FDA-approved orforglipron product with a different active ingredient.

Can it affect oral contraceptives?

The label includes product-specific guidance involving oral contraceptives and interactions; review all medicines with the prescriber.

Related W8MD and WikiMD resources

• W8MD Foundayo doctor
• Orforglipron at WikiMD
• FDA Foundayo information

How W8MD can help

W8MD physicians have more than 20 years of clinical experience and help patients compare medication safety, expected effectiveness, previous attempts, medical conditions, cultural food preferences, insurance benefits, convenience and complete long-term cost. Care may include prescription treatment, nutrition, a medically supervised VLCD for selected patients, sleep-apnea evaluation and weight-maintenance planning.

Brooklyn / New York City

W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235

Serving Brooklyn, Manhattan, Queens, Staten Island, the Bronx, Long Island, nearby New Jersey and Connecticut communities.

Call 718-946-5500

Northeast Philadelphia

W8MD Weight Loss, Sleep & MedSpa
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115

Serving Greater Philadelphia, Bucks and Montgomery counties, South Jersey, nearby Pennsylvania communities and Delaware.

Call 215-676-2334

Visit W8MD.com Review affordable GLP-1 options

Medical notice: General education only. This article does not diagnose, prescribe or replace individualized care. Results vary. Current FDA labeling and clinical judgment control. Treatment requires evaluation; insurance approval and a prescription are not guaranteed. Call 911 for an emergency. Reviewed August 2026.